Based on research submitted to the FDA, in children age 12 through 17, this vaccine is about 78% effective in preventing symptomatic COVID-19 illness.Īn eight-week interval between the first and second doses might be best for some people, especially males ages 12 to 39. This vaccine requires two shots, given three to eight weeks apart. The FDA has also given emergency use authorization to a Novavax COVID-19 vaccine for people age 12 and older. For kids ages 12 through 17, the Moderna COVID-19 vaccine causes an immune response similar to that seen in adults. It contains the same amount of mRNA as the Moderna COVID-19 vaccine for people age 18 and older. This vaccine requires two shots, given four to eight weeks apart. The FDA also has given emergency use authorization to a Moderna COVID-19 vaccine for children ages 12 through 17. This vaccine is 91% effective in preventing severe illness with COVID-19 in people age 16 and older. Research has shown that this vaccine is 100% effective in preventing COVID-19 in children ages 12 through 15. It contains the same amount of mRNA as the Pfizer-BioNTech COVID-19 vaccine for people age 16 and older. The third shot, a booster, is given at least two months after the second shot. The first two are given three to eight weeks apart.
The FDA has approved the Pfizer-BioNTech COVID-19 vaccine, now called Comirnaty, for people age 12 through 17. For kids in this age group, the Moderna vaccine causes an immune response similar to that seen in adults.īoth vaccines contain lower amounts of mRNA than the COVID-19 vaccines for people age 12 and older.Īges 12 through 17. The FDA also has given emergency use authorization to a Moderna COVID-19 vaccine for children ages 6 through 11. Research shows that this vaccine is about 91% effective in preventing COVID-19 in this age group. It contains a lower amount of mRNA than the Pfizer-BioNTech COVID-19 vaccine used for people age 12 and older. This vaccine involves two shots, given three to eight weeks apart. The FDA has given emergency use authorization to a Pfizer-BioNTech COVID-19 vaccine for children ages 5 through 11. For kids ages 2 through 5 years old, the vaccine is estimated to be 37% effective in preventing COVID-19.īoth vaccines contain lower amounts of mRNA than the mRNA COVID-19 vaccines for older children and adults.Īges 5 or 6 through 11. It’s estimated that this vaccine is about 51% effective in preventing COVID-19 in babies ages 6 months through 23 months.
The FDA also has given emergency use authorization to a Moderna COVID-19 vaccine for children ages 6 months through 5 years old.
0 kommentar(er)
